Advanced breast biopsy instrumentation

Medical Services Advisory Committee
Record ID 31999009747
Authors' objectives:

This report summarises the assessment of current evidence for advanced breast biopsy instrumentation.

Authors' recommendations: MSAC noted that the advanced breast biopsy instrumentation (ABBI) is being performed by a small number of surgeons and that it can be claimed under the Medicare Benefits Schedule (MBS). However additional remuneration has been sought. MSAC also noted that the available evidence indicates that ABBI is equivalent to existing diagnostic tests. However, it is considered that there is insufficient evidence to conclude that ABBI is superior to existing diagnostic tests which are on the MBS. MSAC therefore recommended that additional funding is not warranted at this time, and that ABBI should continue to be funded under the existing MBS items.
Authors' methods: Systematic review
Project Status: Completed
Year Published: 1999
English language abstract: An English language summary is available
Publication Type: Not Assigned
Country: Australia
MeSH Terms
  • Biopsy
  • Biopsy, Needle
  • Breast Neoplasms
Organisation Name: Medical Services Advisory Committee
Contact Address: MSAC (MDP 107), GPO Box 9848, Canberra, ACT 2601, Australia. Tel: +61 2 6289 6811; Fax: +61 2 6289 8799.
Contact Name:
Contact Email:
Copyright: Medical Services Advisory Committee
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.